ECOG-ACRIN EA5152

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic

Status:

Temporarily Closed

A Randomized Phase II Trial of Nivolumab, Cabozantinib Plus Nivolumab, and Cabozantinib Plus Nivolumab Plus Ipilimumab in Patients with Previously Treated Non-Squamous NSCLC

NCT#03468985

Effective August 8th, 2018,  EA5152 is temporarily suspended to accrual while a redesign of the study is being developed for chemo/immunotherapy refractory patients.